Tech Company Financing Transactions
Amylyx Pharmaceuticals Funding Round
Amylyx Pharmaceuticals secured a $135 million Series C financing round on 7/21/2021. Investors included Viking Global Investors, 683 Capital and Alpha Wave Ventures.
Transaction Overview
Viking Global Investors (Lead Investor)
private investors (Belinda Termeer)
Morningside Group (Isaac Cheng)
Company Information
Cambridge, MA 02141
USA
Management Team
Browse more venture capital transactions:
Prev: 7/21/2021: Titan Global Capital Management venture capital transaction
Next: 7/21/2021: Inkbit venture capital transaction
Share this article
About Database of VC Transactions
We record every notable VC transaction. VC transactions reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs